| Scrip Code | 543220 |
|---|---|
| NSE Symbol | MAXHEALTH |
| MSEI Symbol | NOTLISTED |
| ISIN | INE027H01010 |
| Name of company | Max Healthcare Institute Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 14-11-2025 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 08-11-2025 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | Medical and Healthcare Services |
| Start date and time of board meeting | 14-11-2025 19:20:00 |
| End date and time of board meeting | 14-11-2025 20:24:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2025 | 01-04-2025 |
| B | Date of end of reporting period | 30-09-2025 | 30-09-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 2,13,547.00 | 4,16,304.00 | |
| Other income | 3,290.00 | 6,941.00 | |
| Total income | 2,16,837.00 | 4,23,245.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0.00 | 0.00 |
| (b) | Purchases of stock-in-trade | 46,515.00 | 91,897.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | (26.00) | (884.00) |
| (d) | Employee benefit expense | 33,832.00 | 67,639.00 |
| (e) | Finance costs | 5,392.00 | 10,877.00 |
| (f) | Depreciation, depletion and amortisation expense | 10,810.00 | 21,224.00 |
| (f) | Other Expenses | ||
| 1 | Professional and consultancy fee | 45,273.00 | 87,912.00 |
| 2 | Other expenses | 30,438.00 | 59,934.00 |
| Total other expenses | 75,711.00 | 1,47,846.00 | |
| Total expenses | 1,72,234.00 | 3,38,599.00 | |
| 3 | Total profit before exceptional items and tax | 44,603.00 | 84,646.00 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | 44,603.00 | 84,646.00 |
| 6 | Tax expense | ||
| 7 | Current tax | 1,029.00 | 10,673.00 |
| 8 | Deferred tax | (5,556.00) | (5,954.00) |
| 9 | Total tax expenses | (4,527.00) | 4,719.00 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 49,130.00 | 79,927.00 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 49,130.00 | 79,927.00 |
| 17 | Other comprehensive income net of taxes | 4.00 | (277.00) |
| 18 | Total Comprehensive Income for the period | 49,134.00 | 79,650.00 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 49,130.00 | 79,927.00 | |
| Total profit or loss, attributable to non-controlling interests | 0.00 | 0.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 49,134.00 | 79,650.00 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0.00 | 0.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 97,224.00 | 97,224.00 | |
| Face value of equity share capital | 10 | 10 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 5.05 | 8.22 | |
| Diluted earnings (loss) per share from continuing operations | 5.02 | 8.17 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 5.05 | 8.22 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 5.02 | 8.17 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | For notes, kindly refer PDF file of Financial Results available on stock exchanges website viz. www.bseindia.com & www.nseindia.com |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| Date of start of reporting period | 01-04-2025 | |
| Date of end of reporting period | 30-09-2025 | |
| Whether results are audited or unaudited | Unaudited | |
| Nature of report standalone or consolidated | Consolidated | |
| Assets | ||
| 1 | Non-current assets | |
| Property, plant and equipment | 5,79,794.00 | |
| Capital work-in-progress | 1,22,590.00 | |
| Investment property | 466.00 | |
| Goodwill | 3,48,825.00 | |
| Other intangible assets | 2,53,506.00 | |
| Intangible assets under development | 36.00 | |
| Biological assets other than bearer plants | 0.00 | |
| Investments accounted for using equity method | 0.00 | |
| Non-current financial assets | ||
| Non-current investments | 546.00 | |
| Trade receivables, non-current | 8,408.00 | |
| Loans, non-current | 57,345.00 | |
| Other non-current financial assets | 20,628.00 | |
| Total non-current financial assets | 86,927.00 | |
| Deferred tax assets (net) | 5,738.00 | |
| Other non-current assets | 62,293.00 | |
| Total non-current assets | 14,60,175.00 | |
| 2 | Current assets | |
| Inventories | 11,439.00 | |
| Current financial asset | ||
| Current investments | 0.00 | |
| Trade receivables, current | 93,802.00 | |
| Cash and cash equivalents | 47,806.00 | |
| Bank balance other than cash and cash equivalents | 1,896.00 | |
| Loans, current | 0.00 | |
| Other current financial assets | 7,614.00 | |
| Total current financial assets | 1,51,118.00 | |
| Current tax assets (net) | ||
| Other current assets | 5,366.00 | |
| Total current assets | 1,67,923.00 | |
| 3 | Non-current assets classified as held for sale | 0.00 |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0.00 |
| Total assets | 16,28,098.00 | |
| Equity and liabilities | ||
| 1 | Equity | |
| Equity attributable to owners of parent | ||
| Equity share capital | 97,224.00 | |
| Other equity | 9,08,017.00 | |
| Total equity attributable to owners of parent | 10,05,241.00 | |
| Non controlling interest | ||
| Total equity | 10,05,241.00 | |
| 2 | Liabilities | |
| Non-current liabilities | ||
| Non-current financial liabilities | ||
| Borrowings, non-current | 2,86,543.00 | |
| Trade payables, non-current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | ||
| Total Trade payable | ||
| Other non-current financial liabilities | 28,218.00 | |
| Total non-current financial liabilities | 3,14,761.00 | |
| Provisions, non-current | 10,485.00 | |
| Deferred tax liabilities (net) | 61,638.00 | |
| Deferred government grants, Non-current | ||
| Other non-current liabilities | 24,169.00 | |
| Total non-current liabilities | 4,11,053.00 | |
| Current liabilities | ||
| Current financial liabilities | ||
| Borrowings, current | 40,959.00 | |
| Trade payables, current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 711.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 85,654.00 | |
| Total Trade payable | 86,365.00 | |
| Other current financial liabilities | 52,895.00 | |
| Total current financial liabilities | 1,80,219.00 | |
| Other current liabilities | 23,791.00 | |
| Provisions, current | 7,794.00 | |
| Current tax liabilities (Net) | ||
| Deferred government grants, Current | ||
| Total current liabilities | 2,11,804.00 | |
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | |
| Total liabilities | 6,22,857.00 | |
| Total equity and liabilites | 16,28,098.00 | |
| Disclosure of notes on assets and liabilities | ||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-07-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 30-09-2025 | 30-09-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2025 | 01-04-2025 |
| B | Date of end of reporting period | 30-09-2025 | 30-09-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement gain/(loss) on defined benefit plans | 2000000 | -32600000 |
| Total Amount of items that will not be reclassified to profit and loss | 20.00 | (326.00) | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 1.00 | (65.00) |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Exchange differences on translation of foreign operations | -1500000 | -1600000 |
| Total Amount of items that will be reclassified to profit and loss | (15.00) | (16.00) | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | 4.00 | (277.00) |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2025 | ||||
| B | Date of end of reporting period | 30-09-2025 | ||||
| C | Whether results are audited or unaudited | Unaudited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 84,646.00 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 9,915.00 | |||||
| Adjustments for decrease (increase) in inventories | (884.00) | |||||
| Adjustments for decrease (increase) in trade receivables, current | (27,228.00) | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | (1,863.00) | |||||
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |||||
| Adjustments for other financial assets, non-current | 0.00 | |||||
| Adjustments for other financial assets, current | (110.00) | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | 5,257.00 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 8,347.00 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 21,224.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | 754.00 | |||||
| Adjustments for provisions, non-current | 0.00 | |||||
| Adjustments for other financial liabilities, current | 0.00 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | 16.00 | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 5,070.00 | |||||
| Adjustments for share-based payments | 2,678.00 | |||||
| Adjustments for fair value losses (gains) | 0.00 | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0.00 | |||||
| Other adjustments to reconcile profit (loss) | 2,997.00 | |||||
| Other adjustments for non-cash items | 0.00 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | 16,033.00 | |||||
| Net cash flows from (used in) operations | 1,00,679.00 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 18,920.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 81,759.00 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 128.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 385.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 281.00 | |||||
| Purchase of property, plant and equipment | 85,890.00 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 19,400.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 400.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 0.00 | |||||
| Interest received | 6,045.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 2,217.00 | |||||
| Net cash flows from (used in) investing activities | (96,604.00) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 10.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 29,119.00 | |||||
| Repayments of borrowings | 5,636.00 | |||||
| Payments of lease liabilities | 1,207.00 | |||||
| Dividends paid | 14,563.00 | |||||
| Interest paid | 11,255.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) financing activities | (3,532.00) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | (18,377.00) | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 25.00 | |||||
| Net increase (decrease) in cash and cash equivalents | (18,352.00) | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 66,158.00 | |||||
| Cash and cash equivalents cash flow statement at end of period | 47,806.00 | |||||